Figure 3. Therapeutic Responses to Efgartigimod.
Changes in the patients' myasthenia gravis activities of daily living. AChR+ = anti–acetylcholine receptor–positive; MuSK+ = anti–muscle-specific receptor tyrosine kinase-positive.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.